Please provide your email address to receive an email when new articles are posted on . “The standard of care for de novo Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) is ...
Randomized controlled trials are considered the golden standard for estimating treatment effect but are costly to perform and not always possible. Observational data, although readily available, is ...